Literature DB >> 1834175

In vitro fusion of lung lamellar bodies and plasma membrane is augmented by lung synexin.

A Chander1, R D Wu.   

Abstract

Lamellar bodies of lung epithelial type II cells undergo fusion with plasma membrane prior to exocytosis of surfactant into the alveolar lumen. Since synexin from adrenal glands promotes aggregation and fusion of chromaffin granules, we purified synexin-like proteins from bovine lung cytosolic fraction, and evaluated their effect on the fusion of isolated lamellar bodies and plasma membrane fractions. Synexin activity, which co-purified with an approx. 47 kDa protein (pI 6.8), was assessed by following calcium-dependent aggregation of liposomes prepared from a mixture of phosphatidylcholine:phosphatidylserine (PC:PS, 3:1, mol/mol). Lung synexin caused aggregation of liposomes approximating lung surfactant lipid-like composition, isolated lamellar bodies, or isolated plasma membrane fraction. Lung synexin promoted fusion only in the presence of calcium. It augmented fusion between lamellar bodies and plasma membranes, lamellar bodies and liposomes, or between two populations of liposomes. However, selectivity with regard to synexin-mediated fusion was observed as synexin did not promote fusion between plasma membrane and liposomes, or between liposomes of surfactant lipid-like composition and other liposomes. These observations support a role for lung synexin in membrane fusion between the plasma membrane and lamellar bodies during exocytosis of lung surfactant, and suggest that such fusion is dependent on composition of interacting membranes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834175     DOI: 10.1016/0005-2760(91)90003-z

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Annexin A7 trafficking to alveolar type II cell surface: possible roles for protein insertion into membranes and lamellar body secretion.

Authors:  Avinash Chander; Tudevdagva Gerelsaikhan; Pavan K Vasa; Kelly Holbrook
Journal:  Biochim Biophys Acta       Date:  2013-02-19

2.  Dynamics of surfactant release in alveolar type II cells.

Authors:  T Haller; J Ortmayr; F Friedrich; H Völkl; P Dietl
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Secretagogues of lung surfactant increase annexin A7 localization with ABCA3 in alveolar type II cells.

Authors:  Tudevdagva Gerelsaikhan; Xiao-Liang Chen; Avinash Chander
Journal:  Biochim Biophys Acta       Date:  2011-09-02

4.  Methylamine decreases trafficking and packaging of newly synthesized phosphatidylcholine in lamellar bodies in alveolar type II cells.

Authors:  A Chander; N Sen; A M Wu; S Higgins; S Wadsworth; A R Spitzer
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

5.  Annexin A7 and SNAP23 interactions in alveolar type II cells and in vitro: a role for Ca(2+) and PKC.

Authors:  Tudevdagva Gerelsaikhan; Pavan Kumar Vasa; Avinash Chander
Journal:  Biochim Biophys Acta       Date:  2012-06-16

6.  Coordinate packaging of newly synthesized phosphatidylcholine and phosphatidylglycerol in lamellar bodies in alveolar type II cells.

Authors:  A Chander; N Sen; S Wadsworth; A R Spitzer
Journal:  Lipids       Date:  2000-01       Impact factor: 1.880

7.  Calcium-dependence of synexin binding may determine aggregation and fusion of lamellar bodies.

Authors:  N Sen; A R Spitzer; A Chander
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

8.  A role for diacylglycerol in annexin A7-mediated fusion of lung lamellar bodies.

Authors:  Avinash Chander; Xiao-Liang Chen; Devendra G Naidu
Journal:  Biochim Biophys Acta       Date:  2007-07-27

9.  Ca(2+)-independent fusion of secretory granules with phospholipase A2-treated plasma membranes in vitro.

Authors:  T Nagao; T Kubo; R Fujimoto; H Nishio; T Takeuchi; F Hata
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

Review 10.  Alveolar epithelial type II cell: defender of the alveolus revisited.

Authors:  H Fehrenbach
Journal:  Respir Res       Date:  2001-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.